Lilly Drops Zepbound Price, Compounders Sue FDA (again) OTP TWD 2.25.25

Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4 📖Paperback: https://amzn.to/4gAXrz4 💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP USE CODE "OTP10" to save 10%. SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.